(Q44659430)

English

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

scientific article published on 12 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

Mitch Dowsett

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Aliana Guerrieri Gonzaga

0 references

1

object named as

Jack Cuzick

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

Ivana Sestak

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

John F Forbes

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Jill Knox

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Simon Cawthorn

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Christobel Saunders

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Nicola Roche

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Robert E Mansel

9

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Gunter von Minckwitz

10

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Bernardo Bonanni

11

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Tiina Palva

12

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Anthony Howell

13

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

IBIS-II investigators

14

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

12 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

383

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

9922

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1041-1048

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Aromatase inhibitors for breast cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Exemestane for breast-cancer prevention in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A breast cancer prediction model incorporating familial and personal risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Menopause and dry eye. A possible relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of androgen, estrogen and progesterone receptor mRNAs in the eye

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast cancer medications and vision: effects of treatments for early-stage disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Steroidogenesis in the skin: implications for local immune functions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Oestrogens and endometrial cancer: effect of other risk factors on the association.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mammographic Density and the Risk and Detection of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962292-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(13)62292-8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44659430&oldid=2031043930"